Stockreport

Immix Biopharma to Launch Underwritten Public Offering [MarketWatch]

Immix Biopharma, Inc.  (IMMX) 
PDF The clinical-stage biopharmaceutical company on Monday said it intends to use the net proceeds from the proposed offering for its working capital and general corporate [Read more]